/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.45%
Natural Gas
+0.25%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.34%
VIX
N/A
Economic Calendar
EUR/USD
+0.45%
Natural Gas
+0.25%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.34%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Binance Founder Changpeng Zhao Bags 4-Month Jail Sentence
about 9 hours ago
Fed Leaves Rate Unchanged, Will Slow The Pace Of Asset Sales
about 11 hours ago
ISM Manufacturing PMI Moved Back Into Contraction Territory In April
about 14 hours ago
Private Payrolls Rise in April, Surpassing Expectations
about 15 hours ago
Euro Area Sovereign Credit: Some Ratings Under Pressure as Fiscal Challenges Mount
1 day ago
CB Consumer Confidence Drops To 97.0, Missing Analyst Expectations
1 day ago
DAX Index Today: Assessing Market Response to FOMC Decision and US Economic Data
about 3 hours ago
Bitcoin (BTC) News Today: US BTC-Spot ETF Market Sinks BTC in Reaction to the Fed
about 3 hours ago
XRP News Today: SEC vs. Ripple Case Update Amidst FOMC Impact
about 4 hours ago
AUD to USD Forecast: Aussie Trade Data and the US Labor Market in Focus
about 6 hours ago
USD/JPY Forecast: BoJ Minutes, Consumer Confidence, and US Labor Data Analysis
about 6 hours ago
Hang Seng Index, ASX 200, Nikkei 225: Powell to Test Hang Seng Winning Streak
about 7 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
CYTK
news
Cytokinetics Inc
Follow
CYTK
(
Nasdaq - US
)
N/A
63.35
+2.03 (+3.31%)
in
:
usd
•
As of: May 01, 2024 15:59
UTC -4
Open
61.26
High
64.34
Low
61.25
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Zacks Investment Research
15 hours ago
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CYTK
+3.31%
InvestorPlace
Apr 26, 2024
3 Biotech Stocks to Buy on the Dip: April 2024
CYTK
+3.31%
VKTX
-4.03%
Market Watch
Apr 10, 2024
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
CYTK
+3.31%
NVO
+0.68%
VKTX
-4.03%
Seeking Alpha
Apr 1, 2024
Cytokinetics, Incorporated: Buyout Speculation Persists
CYTK
+3.31%
The Motley Fool
Mar 20, 2024
2 Incredible Growth Stocks to Buy Right Now
CYTK
+3.31%
VKTX
-4.03%
InvestorPlace
Mar 19, 2024
7 Biotech Stocks Ready to Ride the Sector's Resurgence
CYTK
+3.31%
TECH
+16.22%
Seeking Alpha
Mar 16, 2024
Cytokinetics: CEO Talks Down Buyout Prospects
CYTK
+3.31%
InvestorPlace
Mar 13, 2024
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
CYTK
+3.31%
SWTX
+0.17%
VKTX
-4.03%
Seeking Alpha
Feb 28, 2024
Cytokinetics, Incorporated (CYTK) Q4 2023 Earnings Call Transcript
CYTK
+3.31%
Zacks Investment Research
Feb 27, 2024
Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
CYTK
+3.31%
InvestorPlace
Feb 8, 2024
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
CYTK
+3.31%
RPRX
+1.34%
Investors Business Daily
Feb 8, 2024
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
CYTK
+3.31%
Zacks Investment Research
Jan 12, 2024
Cytokinetics (CYTK) Down on Report of Novartis Not Interested
CYTK
+3.31%
Seeking Alpha
Jan 12, 2024
Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
CYTK
+3.31%
WSJ
Jan 11, 2024
Novartis Pursuit of Cytokinetics Cools
CYTK
+3.31%
NVS
+0.38%
Zacks Investment Research
Jan 9, 2024
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
CYTK
+3.31%
Invezz
Jan 8, 2024
Novartis in advanced talks to buy Cytokinetics
CYTK
+3.31%
NVS
+0.38%
Investors Business Daily
Jan 8, 2024
Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal
CYTK
+3.31%
NVS
+0.38%
Market Watch
Jan 8, 2024
Novartis, Cytokinetics near merger: report
CYTK
+3.31%
NVS
+0.38%
WSJ
Jan 8, 2024
Novartis in Advanced Talks to Buy Cytokinetics
CYTK
+3.31%
NVS
+0.38%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker